Immunophenotypic Abnormalities in Acute Myeloid Leukemia Associated with NPM1 Mutation and Clinical Significance of Minimal Residual Disease Detection

被引:0
|
作者
Zhou, Yi [1 ]
Wu, David [1 ]
Chen, Xueyan [1 ]
Fromm, Jonathan R. [1 ]
Wood, Brent L. [1 ]
机构
[1] Univ Washington, Seattle, WA 98195 USA
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
1531
引用
收藏
页码:387A / 388A
页数:2
相关论文
共 50 条
  • [21] Effective NPM1 plasmid standards selection for minimal/measurable residual disease monitoring in acute myeloid leukemia
    Folta, Adam
    Sasinkova, Marketa
    Durinikova, Anna
    Drncova, Marie
    Weinbergerova, Barbora
    Mayer, Jiri
    Jeziskova, Ivana
    MOLECULAR BIOLOGY REPORTS, 2022, 49 (08) : 8169 - 8172
  • [22] Effective NPM1 plasmid standards selection for minimal/measurable residual disease monitoring in acute myeloid leukemia
    Adam Folta
    Marketa Sasinkova
    Anna Durinikova
    Marie Drncova
    Barbora Weinbergerova
    Jiri Mayer
    Ivana Jeziskova
    Molecular Biology Reports, 2022, 49 : 8169 - 8172
  • [23] Quantitative assessment of minimal residual disease in acute myeloid leukemia carrying nucleophosmin (NPM1) gene mutations
    P Gorello
    G Cazzaniga
    F Alberti
    M G Dell'Oro
    E Gottardi
    G Specchia
    G Roti
    R Rosati
    M F Martelli
    D Diverio
    F Lo Coco
    A Biondi
    G Saglio
    C Mecucci
    B Falini
    Leukemia, 2006, 20 : 1103 - 1108
  • [24] Quantitative assessment of minimal residual disease in acute myeloid leukemia carrying nucleophosmin (NPM1) gene mutations
    Gorello, P.
    Cazzaniga, G.
    Alberti, F.
    Dell'Oro, M. G.
    Gottardi, E.
    Specchia, G.
    Roti, G.
    Rosati, R.
    Martelli, M. F.
    Diverio, D.
    Lo Coco, F.
    Biondi, A.
    Saglio, G.
    Mecucci, C.
    Falini, B.
    LEUKEMIA, 2006, 20 (06) : 1103 - 1108
  • [25] Quantitative detection of IDH2 mutation for minimal residual disease monitoring in patients with acute myeloid leukemia and its comparison with mutations in NPM1 gene
    Jeziskova, Ivana
    Razga, Filip
    Toskova, Martina
    Dvorakova, Dana
    Timilsina, Shira
    Mayer, Jiri
    Racil, Zdenek
    LEUKEMIA & LYMPHOMA, 2013, 54 (04) : 867 - 870
  • [26] ANALYSIS OF THE INFLUENCE OF DNMT3A ON MEASURABLE RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA WITH MUTATION OF NPM1
    Onate, G.
    Bataller, A.
    Garrido, A.
    Esteve, J.
    Arnan, M.
    Vives, S.
    Coll, R.
    Bargay, J.
    Salamero, O.
    Escoda, L.
    Garcia, A.
    Queipo de Llano, M. P.
    Aljarilla, A.
    Brunet, S.
    Nomdedeu, J. F.
    Sierra, J.
    Pratcorona, M.
    HAEMATOLOGICA, 2019, 104 : 267 - 267
  • [27] Evaluation of NPM1 Drop Off Droplet Digital PCR Assay for Minimal Residual Disease Detection in Acute Myeloid Leukemia Patients
    Mehrotra, M.
    Guan, M.
    Manning, C.
    Dupuy, A.
    Barbari, S.
    Houldsworth, J.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2024, 26 (11): : S158 - S158
  • [28] Evaluation of NPM1 Mutation Detection by Droplet Digital PCR for Minimal Residual Disease Detection
    Walder, R. Y.
    Stence, A. A.
    Sompallae, K.
    Sompallae, R.
    Guseva, N. V.
    Ma, D.
    Snow, A. N.
    Bossler, A. D.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2018, 20 (06): : 920 - 920
  • [29] Monitoring of minimal residual disease in acute myeloid leukemia with frequent and rare patient-specific NPM1 mutations
    Dvorakova, Dana
    Racil, Zdenek
    Jeziskova, Ivana
    Palasek, Ivo
    Protivankova, Marketa
    Lengerova, Martina
    Razga, Filip
    Mayer, Jiri
    AMERICAN JOURNAL OF HEMATOLOGY, 2010, 85 (12) : 926 - 929
  • [30] Minimal Residual Disease Monitoring of Acute Myeloid Leukemia by Massively Multiplex Digital PCR in Patients with NPM1 Mutations
    Mencia-Trinchant, Nuria
    Hu, Yang
    Alas, Maria Antonina
    Ali, Fatima
    Wouters, Bas J.
    Lee, Sangmin
    Ritchie, Ellen K.
    Desai, Pinkal
    Guzman, Monica L.
    Roboz, Gail J.
    Hassane, Duane C.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2017, 19 (04): : 537 - 548